Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zimmermann

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Blood|January 12, 2024
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatmentBarbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Blood|February 15, 2007
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective studyHenrik Hasle, Todd A Alonzo, Anne Auvrignon, et al.
Cancers|April 30, 2021
Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment RecommendationsBirgit Burkhardt, Mary Taj, Nathalie Garnier, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Haematologica|April 25, 2020
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic targetHugo Larose, Nina Prokoph, Jamie D Matthews, et al.
Blood|May 10, 2011
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen, Susana C Raimondi, Jochen Harbott, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Blood|January 12, 2024
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatmentBarbara Buldini, Elena Varotto, Margarita Maurer-Granofszky, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Blood|February 15, 2007
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective studyHenrik Hasle, Todd A Alonzo, Anne Auvrignon, et al.
Cancers|April 30, 2021
Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment RecommendationsBirgit Burkhardt, Mary Taj, Nathalie Garnier, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Haematologica|April 25, 2020
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic targetHugo Larose, Nina Prokoph, Jamie D Matthews, et al.
Blood|May 10, 2011
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen, Susana C Raimondi, Jochen Harbott, et al.
Pageof 28